SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-104599
Filing Date
2021-08-13
Accepted
2021-08-13 07:02:49
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pnt-20210630x10q.htm   iXBRL 10-Q 1280808
2 EX-31.1 pnt-20210630xex31d1.htm EX-31.1 13459
3 EX-31.2 pnt-20210630xex31d2.htm EX-31.2 13920
4 EX-32 pnt-20210630xex32.htm EX-32 13545
  Complete submission text file 0001104659-21-104599.txt   4818017

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pnt-20210630.xsd EX-101.SCH 43908
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pnt-20210630_cal.xml EX-101.CAL 35714
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pnt-20210630_def.xml EX-101.DEF 126519
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pnt-20210630_lab.xml EX-101.LAB 358238
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pnt-20210630_pre.xml EX-101.PRE 257915
10 EXTRACTED XBRL INSTANCE DOCUMENT pnt-20210630x10q_htm.xml XML 673916
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39373 | Film No.: 211169685
SIC: 2834 Pharmaceutical Preparations